A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression

Authors
Category Primary study
ConferenceJournal of Clinical Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 378e6f1cf1dffa1ecdd7414c794046765abf34da
First added on: Feb 10, 2025